Annual Cash & Cash Equivalents
$4.17 M
-$5.55 M-57.09%
31 May 2024
Summary:
Biomerica annual cash & cash equivalents is currently $4.17 million, with the most recent change of -$5.55 million (-57.09%) on 31 May 2024. During the last 3 years, it has fallen by -$29.30 thousand (-0.70%). BMRA annual cash & cash equivalents is now -57.09% below its all-time high of $9.72 million, reached on 31 May 2023.BMRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.82 M
-$1.35 M-32.37%
01 August 2024
Summary:
Biomerica quarterly cash and cash equivalents is currently $2.82 million, with the most recent change of -$1.35 million (-32.37%) on 01 August 2024. Over the past year, it has dropped by -$5.17 million (-64.70%). BMRA quarterly cash and cash equivalents is now -72.28% below its all-time high of $10.17 million, reached on 28 February 2022.BMRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.1% | -64.7% |
| 3 y3 years | -0.7% | -43.6% |
| 5 y5 years | +507.2% | +249.2% |
BMRA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -57.1% | at low | -72.3% | at low |
| 5 y | 5 years | -57.1% | +507.2% | -72.3% | +249.2% |
| alltime | all time | -57.1% | +3377.9% | -72.3% | +7243.8% |
Biomerica Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2024 | - | $2.82 M(-32.4%) |
| May 2024 | $4.17 M(-57.1%) | $4.17 M(-21.6%) |
| Feb 2024 | - | $5.32 M(-25.4%) |
| Nov 2023 | - | $7.13 M(-10.7%) |
| Aug 2023 | - | $7.99 M(-17.8%) |
| May 2023 | $9.72 M(+64.3%) | $9.72 M(+190.5%) |
| Feb 2023 | - | $3.35 M(-34.0%) |
| Nov 2022 | - | $5.07 M(-16.6%) |
| Aug 2022 | - | $6.08 M(+2.7%) |
| May 2022 | $5.92 M(+40.9%) | $5.92 M(-41.8%) |
| Feb 2022 | - | $10.17 M(+41.3%) |
| Nov 2021 | - | $7.20 M(+44.1%) |
| Aug 2021 | - | $5.00 M(+19.0%) |
| May 2021 | $4.20 M(-51.4%) | $4.20 M(-20.4%) |
| Feb 2021 | - | $5.27 M(-7.2%) |
| Nov 2020 | - | $5.68 M(-18.4%) |
| Aug 2020 | - | $6.96 M(-19.4%) |
| May 2020 | $8.64 M(+1158.2%) | $8.64 M(+261.3%) |
| Feb 2020 | - | $2.39 M(+181.0%) |
| Nov 2019 | - | $851.00 K(+5.4%) |
| Aug 2019 | - | $807.60 K(+17.6%) |
| May 2019 | $686.80 K(-43.0%) | $686.80 K(-25.2%) |
| Feb 2019 | - | $917.90 K(-18.4%) |
| Nov 2018 | - | $1.12 M(+92.7%) |
| Aug 2018 | - | $583.70 K(-51.6%) |
| May 2018 | $1.20 M(-1.7%) | $1.20 M(+101.8%) |
| Feb 2018 | - | $597.00 K(-27.0%) |
| Nov 2017 | - | $817.80 K(-24.3%) |
| Aug 2017 | - | $1.08 M(-11.8%) |
| May 2017 | $1.23 M(-35.1%) | $1.23 M(-20.5%) |
| Feb 2017 | - | $1.54 M(-4.3%) |
| Nov 2016 | - | $1.61 M(-11.3%) |
| Aug 2016 | - | $1.82 M(-3.8%) |
| May 2016 | $1.89 M(+73.6%) | $1.89 M(+119.9%) |
| Feb 2016 | - | $859.10 K(+33.6%) |
| Nov 2015 | - | $643.00 K(-28.0%) |
| Aug 2015 | - | $893.30 K(-17.9%) |
| May 2015 | $1.09 M(-27.9%) | $1.09 M(-7.1%) |
| Feb 2015 | - | $1.17 M(-30.0%) |
| Nov 2014 | - | $1.67 M(+1.6%) |
| Aug 2014 | - | $1.65 M(+9.1%) |
| May 2014 | $1.51 M(-38.9%) | $1.51 M(-9.4%) |
| Feb 2014 | - | $1.67 M(+1.1%) |
| Nov 2013 | - | $1.65 M(-21.0%) |
| Aug 2013 | - | $2.09 M(-15.6%) |
| May 2013 | $2.47 M(+129.3%) | $2.47 M(+6.5%) |
| Feb 2013 | - | $2.32 M(+94.1%) |
| Nov 2012 | - | $1.19 M(-8.1%) |
| Aug 2012 | - | $1.30 M(+20.6%) |
| May 2012 | $1.08 M(+8.9%) | $1.08 M(+19.9%) |
| Feb 2012 | - | $898.50 K(-7.0%) |
| Nov 2011 | - | $966.00 K(-5.4%) |
| Aug 2011 | - | $1.02 M(+3.2%) |
| May 2011 | $989.30 K(-6.2%) | $989.30 K(+9.4%) |
| Feb 2011 | - | $904.10 K(-7.0%) |
| Nov 2010 | - | $972.10 K(+19.6%) |
| Aug 2010 | - | $812.90 K(-23.0%) |
| May 2010 | $1.06 M(-33.9%) | $1.06 M(-6.6%) |
| Feb 2010 | - | $1.13 M(-19.5%) |
| Nov 2009 | - | $1.40 M(-17.1%) |
| Aug 2009 | - | $1.69 M(+6.0%) |
| May 2009 | $1.60 M(-21.1%) | $1.60 M(+4.4%) |
| Feb 2009 | - | $1.53 M(-14.5%) |
| Nov 2008 | - | $1.79 M(-8.8%) |
| Aug 2008 | - | $1.96 M(-3.0%) |
| May 2008 | $2.02 M(+291.3%) | $2.02 M(+145.9%) |
| Feb 2008 | - | $822.30 K(+1.8%) |
| Nov 2007 | - | $807.80 K(-18.5%) |
| Aug 2007 | - | $990.60 K(+91.6%) |
| May 2007 | $516.90 K | $516.90 K(+677.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2007 | - | $66.50 K(+73.2%) |
| Nov 2006 | - | $38.40 K(-57.1%) |
| Aug 2006 | - | $89.60 K(-25.3%) |
| May 2006 | $119.90 K(-65.9%) | $119.90 K(+154.0%) |
| Feb 2006 | - | $47.20 K(-68.6%) |
| Nov 2005 | - | $150.30 K(-33.7%) |
| Aug 2005 | - | $226.70 K(-35.6%) |
| May 2005 | $351.90 K(-0.1%) | $351.90 K(+59.2%) |
| Feb 2005 | - | $221.00 K(-1.1%) |
| Nov 2004 | - | $223.40 K(+58.3%) |
| Aug 2004 | - | $141.10 K(-60.0%) |
| May 2004 | $352.40 K(-32.9%) | $352.40 K(+97.0%) |
| Feb 2004 | - | $178.90 K(-39.7%) |
| Nov 2003 | - | $296.90 K(+3.2%) |
| Aug 2003 | - | $287.70 K(-45.2%) |
| May 2003 | $525.20 K(+59.5%) | $525.20 K(-9.5%) |
| Feb 2003 | - | $580.10 K(+18.4%) |
| Nov 2002 | - | $490.00 K(+80.5%) |
| Aug 2002 | - | $271.50 K(-17.6%) |
| May 2002 | $329.30 K(+141.6%) | $329.30 K(+177.0%) |
| Feb 2002 | - | $118.90 K(+120.6%) |
| Nov 2001 | - | $53.90 K(-63.9%) |
| Aug 2001 | - | $149.40 K(+9.6%) |
| May 2001 | $136.30 K(-78.5%) | $136.30 K(-41.9%) |
| Feb 2001 | - | $234.40 K(-5.1%) |
| Nov 2000 | - | $247.00 K(-62.5%) |
| Aug 2000 | - | $658.10 K(+3.8%) |
| May 2000 | $634.20 K(-62.7%) | $634.20 K(-61.5%) |
| Feb 2000 | - | $1.65 M(-36.6%) |
| Nov 1999 | - | $2.60 M(-23.5%) |
| Aug 1999 | - | $3.40 M(+100.0%) |
| May 1999 | $1.70 M(-5.6%) | $1.70 M(0.0%) |
| Feb 1999 | - | $1.70 M(-5.6%) |
| Nov 1998 | - | $1.80 M(0.0%) |
| Aug 1998 | - | $1.80 M(0.0%) |
| May 1998 | $1.80 M(+5.9%) | $1.80 M(0.0%) |
| Feb 1998 | - | $1.80 M(0.0%) |
| Nov 1997 | - | $1.80 M(0.0%) |
| Aug 1997 | - | $1.80 M(+5.9%) |
| May 1997 | $1.70 M(+183.3%) | $1.70 M(-10.5%) |
| Feb 1997 | - | $1.90 M(+111.1%) |
| Nov 1996 | - | $900.00 K(-10.0%) |
| Aug 1996 | - | $1.00 M(+66.7%) |
| May 1996 | $600.00 K(-14.3%) | $600.00 K(0.0%) |
| Feb 1996 | - | $600.00 K(+50.0%) |
| Nov 1995 | - | $400.00 K(0.0%) |
| Aug 1995 | - | $400.00 K(-42.9%) |
| May 1995 | $700.00 K(-12.5%) | $700.00 K(-12.5%) |
| Feb 1995 | - | $800.00 K(+33.3%) |
| Nov 1994 | - | $600.00 K(0.0%) |
| Aug 1994 | - | $600.00 K(-25.0%) |
| May 1994 | $800.00 K(+166.7%) | $800.00 K(+100.0%) |
| Feb 1994 | - | $400.00 K(-33.3%) |
| Nov 1993 | - | $600.00 K(+50.0%) |
| Aug 1993 | - | $400.00 K(+33.3%) |
| May 1993 | $300.00 K(0.0%) | $300.00 K(+50.0%) |
| Feb 1993 | - | $200.00 K(-60.0%) |
| Nov 1992 | - | $500.00 K(0.0%) |
| Aug 1992 | - | $500.00 K(+66.7%) |
| May 1992 | $300.00 K(+50.0%) | $300.00 K(+50.0%) |
| Feb 1992 | - | $200.00 K(+100.0%) |
| Nov 1991 | - | $100.00 K(0.0%) |
| Aug 1991 | - | $100.00 K(-50.0%) |
| May 1991 | $200.00 K(-94.6%) | $200.00 K(0.0%) |
| Feb 1991 | - | $200.00 K(+100.0%) |
| Nov 1990 | - | $100.00 K(-97.3%) |
| May 1988 | $3.70 M(-21.3%) | $3.70 M(-21.3%) |
| May 1987 | $4.70 M(-24.2%) | $4.70 M(-24.2%) |
| May 1986 | $6.20 M(-4.6%) | $6.20 M(-4.6%) |
| May 1985 | $6.50 M(-4.4%) | $6.50 M(-4.4%) |
| May 1984 | $6.80 M | $6.80 M |
FAQ
- What is Biomerica annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Biomerica?
- What is Biomerica annual cash & cash equivalents year-on-year change?
- What is Biomerica quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Biomerica?
- What is Biomerica quarterly cash and cash equivalents year-on-year change?
What is Biomerica annual cash & cash equivalents?
The current annual cash & cash equivalents of BMRA is $4.17 M
What is the all time high annual cash & cash equivalents for Biomerica?
Biomerica all-time high annual cash & cash equivalents is $9.72 M
What is Biomerica annual cash & cash equivalents year-on-year change?
Over the past year, BMRA annual cash & cash equivalents has changed by -$5.55 M (-57.09%)
What is Biomerica quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BMRA is $2.82 M
What is the all time high quarterly cash and cash equivalents for Biomerica?
Biomerica all-time high quarterly cash and cash equivalents is $10.17 M
What is Biomerica quarterly cash and cash equivalents year-on-year change?
Over the past year, BMRA quarterly cash and cash equivalents has changed by -$5.17 M (-64.70%)